Evidence map›Paper›PMID 32908731›Full record

ArticleCase reports in hematology2020

A Rare Case of Coexisting Breast Cancer and Refractory Acute Myeloid Leukemia.

L Ballotta, S M Trisolini, A P Iori, U La Rocca, A Micozzi, G Gentile, T De Giacomo, A Guarini, R Foà, S Capria

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

L BallottaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0003-2731-2074
S M TrisoliniHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
A P IoriHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
U La RoccaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
A MicozziHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
G GentileHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
T De GiacomoDepartment of Cardiovascular and Thoracic Surgery "Paride Stefanini", Sapienza University, Policlinico Umberto I, Rome, Italy.
A GuariniHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
R FoàHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
S CapriaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Sapienza University of Rome · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of acute myeloid leukemia (AML) within six months from a diagnosis of breast cancer (BC) is rarely reported in the literature, and it is associated with a poor prognosis. We report herein the case of a 40-year-old woman referred to our centre affected by BC and simultaneous AML. The patient proved refractory to first line therapy and achieved complete remission (CR) with a clofarabine-based regimen followed by allogeneic stem cell transplantation (ASCT). Both during salvage chemotherapy and after ASCT, the patient presented severe infectious complications ( acute cholecistytis and

Identifiers

PMID32908731
PMCPMC7468610
OpenAlexW3080139989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.